Navigation Links
Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Date:4/24/2012

sales, earnings, return on equity, cost savings, process improvements, free cash flow, share repurchases, capital expenditures, acquisitions and other matters.  These statements are based on assumptions regarding Company operations, investments and acquisitions and conditions in the markets the Company serves.  The Company believes these assumptions are reasonable and well founded.  Such statements in this release are subject to risks and uncertainties, including, among others, certain economic, political and technological factors.  Actual results could differ materially from those stated or implied in this release due to such factors as (1) global economic conditions, (2) changes in pricing and the competitive environment and the global demand for the Company's products, (3) fluctuations in foreign currency exchange rates, (4) changes in research funding and the success of research and development activities, (5) failure of planned sales initiatives in our Research and SAFC business units, (6) dependence on uninterrupted manufacturing operations and global supply chain, (7) changes in the regulatory environment in which the Company operates, (8) changes in worldwide tax rates or tax benefits from domestic and international operations, including the matters described in Note 10 – Income Taxes, to the Company's consolidated financial statements included in Item 8, Part II in the Company's Annual Report on Form 10-K for the year ended December 31, 2011 (the "10-K"), (9) exposure to litigation, including product liability claims, (10) the ability to maintain adequate quality standards, (11) reliance on third party package delivery services, (12) an unanticipated increase in interest rates, (13) other changes in the business environment in which the Company operates, (14) the outcome of the outstanding matters described in Note 11 – Contingent Liabilities and Commitments, to the Company's consolidated financial statements included in Ite
'/>"/>
SOURCE Sigma-Aldrich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. CRF Institute Names Sigma-Aldrich Top Employer Europe 2012
2. Sigma-Aldrich Enhances Asia-Pacific Customer Support With New Distribution and Packaging Capabilities in India
3. Sigma-Aldrich Corporation Will Hold Its Business Review March 29, 2012
4. Sigma-Aldrich (Nasdaq:SIAL) Declares Increased Quarterly Dividend
5. Sigma-Aldrich Completes Acquisition of BioReliance
6. Avista Capital Partners Agrees to Sell BioReliance to Sigma-Aldrich Corporation
7. Sigma-Aldrich Corporation to Present at Upcoming Investor Conference
8. Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81.
9. Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences
10. Sigma-Aldrich (NASDAQ:SIAL) Declares Quarterly Dividend
11. Sigma-Aldrich Opens European Headquarters in St. Gallen, Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 19, 2014 Luoxis Diagnostics, Inc. ... (NYSE MKT: AMPE), today announced an upcoming ... of the American Academy of Surgical Trauma (AAST) ... Philadelphia, Pennsylvania that will ... report results from a recently completed five-year prospective ...
(Date:8/18/2014)... Japan , Aug. 19, 2014 Boston ... INTECC (Securities Code 7747, Second Section, Tokyo ... to develop a new, differentiated fractional flow reserve (FFR) ... intended to improve handling compared to existing FFR wires. ... in interventional cardiology that exceeds $250 million worldwide and ...
(Date:8/18/2014)... , Aug. 18, 2014 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p01597713/Bioseparation-Systems-for-Global-Biopharmaceutical-Markets.html ... into three types: chromatography, membranes/filters and centrifuges. ... increasing and fueling growth of the global ...
Breaking Medicine Technology:Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 2Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 3Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 2Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 3Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 4Bioseparation Systems for Global Biopharmaceutical Markets 2Bioseparation Systems for Global Biopharmaceutical Markets 3Bioseparation Systems for Global Biopharmaceutical Markets 4Bioseparation Systems for Global Biopharmaceutical Markets 5Bioseparation Systems for Global Biopharmaceutical Markets 6Bioseparation Systems for Global Biopharmaceutical Markets 7Bioseparation Systems for Global Biopharmaceutical Markets 8Bioseparation Systems for Global Biopharmaceutical Markets 9Bioseparation Systems for Global Biopharmaceutical Markets 10Bioseparation Systems for Global Biopharmaceutical Markets 11Bioseparation Systems for Global Biopharmaceutical Markets 12
... 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: ... previously announced underwritten public offering of 16,300,000 shares of ... per share to the public. The gross proceeds to ... $130,400,000, before deducting underwriting discounts and commissions, and other ...
... 26, 2011 American Scientific Resources, Inc. (OTCQB: ASFX) ... and Sanomedics International Holdings, Inc., and its affiliates, have ... United States District Court for the Southern District of ... judge, Hon. Ursula Ungaro, and the case has been ...
Cached Medicine Technology:Rigel Announces Pricing of Public Offering of Common Stock 2Rigel Announces Pricing of Public Offering of Common Stock 3American Scientific Resources, Inc. Announces Dismissal of Sanomedics International Holdings, Inc. lawsuit 2
(Date:8/20/2014)... DC (PRWEB) August 20, 2014 Hope ... Heart, Give Hope® Celebration to be hosted in Washington, ... and Navy Club. This signature event honors the courage ... families of the fallen. Proceeds from the Got Heart, ... a national nonprofit dedicated to restoring a sense of ...
(Date:8/20/2014)... Building on growing success by applying ... iii and iv pressure ulcers with extremely high ... A company spokesperson commented that these accuracy levels ... settings. The resulting capabilities can be extended to ... to help providers avoid financial losses while improving ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Blaine ... the innovative RevitaDERM® Psoriasis Treatment to ... associated with psoriasis. This all-in-one product was created ... RevitaDERM® Psoriasis Treatment is powered by coal tar ... associated with this effective ingredient. , RevitaDERM® ...
(Date:8/20/2014)... 2014 AttorneyOne.com, a recognized authority on law, ... the FDA on Sodium Chloride IV . , ... of Sodium Chloride IV 0.9%, USP 1000 mL, by Baxter ... of particulate matter. Sodium Chloride Injection, USP is used as ... solution in hemodialysis procedures. , The reason for ...
(Date:8/20/2014)... NY (PRWEB) August 20, 2014 At this ... of Africa. To help eliminate the root cause of the ... recently teamed up with the nonprofit organization Books For Africa ... Africans: How Every African Can Live the Life of Their ... , This book equips Africans with the tools they need ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors Announces Got Heart, Give Hope Celebration in Washington, DC 2Health News:Jvion Achieves Benchmark Accuracy in Pressure Ulcer Prediction 2Health News:RevitaDERM® Psoriasis Treatment Now Available At Over 7,600 CVS/pharmacies 2Health News:Sodium Chloride IV 0.9% by Baxter Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Ebola, Poverty, and a Partnership for Africa—How Everyone Can Help 2Health News:Ebola, Poverty, and a Partnership for Africa—How Everyone Can Help 3
... broader, patient-centered treatment choices to those ... dealing with substance use disorders, WASHINGTON, ... awarded a $7 million contract to provide technical,assistance to the ... Mental Health Services Administration (SAMHSA) within,the U.S. Department of Health ...
... Serious subject for the funnies becomes basis for Lisa,s Legacy ... in a comic strip,Funky Winkerbean creator Tom Batiuk has depicted ... of breast cancer. Lisa Moore, a major,character who is battling ... Oct. 4, 2007, leaving behind her husband, Les, and their,five-year-old ...
... 2, 2007 Phylonix Pharmaceuticals, Inc. today announced that it ... Grant (SBIR) from the National Eye Institute of the National ... for drug screening. The grant for New Models for ... of three years., The eye is a highly conserved organ ...
... Paramed Systems announced today,the release of their Mobility Offers ... fire, emergency medical, and,rehabilitating patients safely and easily both ... a button. Paramed developed the dual-track MOV in ... capable of safe stairway ascents and,descents. The MOV has ...
... a Full-featured Solution for Home ... DALLAS, Oct. 2 Today, Dynamic Energy Systems, Inc.,(DES) ... on- demand, on-line software solution. The online version,provides access ... so excited to offer our customers a choice when ...
... the Modernization, of its Health Information System Based on BEA ... ... (Assistance Publique - Hopitaux de Marseille) has chosen BEA ... Integration offers an interoperability platform upon which AP-HM has built ...
Cached Medicine News:Health News:Altarum Wins $7 Million Contract to Provide Technical Assistance to the Access to Recovery Program 2Health News:University Hospitals Ireland Cancer Center and Funky Winkerbean Cartoonist Tom Batiuk Establish Lisa's Legacy Fund for Cancer Research and Education 2Health News:University Hospitals Ireland Cancer Center and Funky Winkerbean Cartoonist Tom Batiuk Establish Lisa's Legacy Fund for Cancer Research and Education 3Health News:University Hospitals Ireland Cancer Center and Funky Winkerbean Cartoonist Tom Batiuk Establish Lisa's Legacy Fund for Cancer Research and Education 4Health News:NIH awards Phylonix phase II SBIR to develop zebrafish models for eye diseases 2Health News:AP-HM Places Patients at the Core of its Service-Oriented Architecture with BEA Systems 2Health News:AP-HM Places Patients at the Core of its Service-Oriented Architecture with BEA Systems 3Health News:AP-HM Places Patients at the Core of its Service-Oriented Architecture with BEA Systems 4Health News:AP-HM Places Patients at the Core of its Service-Oriented Architecture with BEA Systems 5
Femoral selective diagnostic catheter.The material used is polyurethane (DUCOR). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Jography angiographic catheter has a new material combination, a patented angled weld, a flat wire braid design with a XXL lumen. It also has an atraumatic soft tip....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
... of cardiology catheters. Available in both Softouch ... with excellent torque, new wire-braid technology for ... large inner lumens for excellent flow rates. ... French sizes with pressure ratings up to ...
Medicine Products: